Clinical Trials Directory

Trials / Conditions / Urothelial Carcinoma of the Renal Pelvis and Ureter

Urothelial Carcinoma of the Renal Pelvis and Ureter

8 registered clinical trials studyying Urothelial Carcinoma of the Renal Pelvis and Ureter — 6 currently recruiting.

StatusTrialSponsorPhase
RecruitingBladder EpiCheck European Haematuria Study
NCT06818136
Nucleix Ltd.—
RecruitingClinical Trial of AM80 in Combination With Gemcitabine, Cisplatin, and Nivolumab in Patients With Urothelial C
NCT06983210
Nagoya UniversityPhase 2
Recruiting9MW2821 + Toripalimab vs 9MW2821 for 1st Line Locally Advanced or Metastatic Urothelial Carcinoma
NCT06823427
Mabwell (Shanghai) Bioscience Co., Ltd.Phase 2
Not Yet RecruitingNeoadjuvant Radiotherapy for High-risk UTUC
NCT06472752
Peking University First Hospital—
RecruitingMulticenter Clinical Trial of ST-02 for Ablation of Upper Tract Urothelial Carcinoma
NCT06124976
University of British ColumbiaPhase 2 / Phase 3
RecruitinguTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
NCT05874921
UroGen Pharma Ltd.—
TerminatedA Phase 2 Study of Sitravatinib in Combination With PD-(L)1 Checkpoint Inhibitor Regimens in Patients With Adv
NCT03606174
Mirati Therapeutics Inc.Phase 2
AvailableNamed Patient Program for Mitomycin for Pyelocalyceal Solution
NCT05494411
UroGen Pharma Ltd.—